In fact, many mobile operators are betting on 5G to diversify their revenue streams, as conventional voice and data service ARPUs decline globally. For example, South Korea’s KT has established a dedicated business unit for holograms, which it envisions to be a key source of revenue for its future 5G network.

At present, the 3GPP and other SDOs (Standards Development Organizations) are engaged in defining the first phase of 5G specifications. However, pre-standards 5G network rollouts are already underway, most notably in the United States and South Korea, as mobile operators rush to be the first to offer 5G services. SNS Research estimates that by the end of 2017, pre-standards 5G network investments are expected to account for over $250 Million.

Although 2020 has conventionally been regarded as the headline date for 5G commercialization, the very first standardized deployments of the technology are expected to be commercialized as early as 2019 with the 3GPP’s initial 5G specifications set to be implementation-ready by March 2018. Between 2019 and 2025, we expect the 5G network infrastructure market to aggressively grow at a CAGR of nearly 70%, eventually accounting for $28 Billion in annual spending by the end of 2025. These infrastructure investments will be complemented by annual shipments of up to 520 Million 5G-capable devices.

The “5G Wireless Ecosystem: 2017 – 2030 – Technologies, Applications, Verticals, Strategies & Forecasts” report presents an in-depth assessment of the emerging 5G ecosystem including key market drivers, challenges, enabling technologies, usage scenarios, vertical market applications, mobile operator deployment commitments, case studies, spectrum availability/allocation, standardization, research initiatives and vendor strategies. The report also presents forecasts for 5G investments and operator services.
The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report, as well as a 5G deployment tracking database covering over 60 global 5G trials, demos and commercial deployment commitments (as of Q1’2017).

Topics Covered
The report covers the following topics:
– 5G NR (New Radio) and NextGen (Next Generation) system architecture
– Market drivers and barriers to the adoption of 5G networks
– 5G requirements, usage scenarios, vertical markets and applications
– Key enabling technologies including air interface design, higher frequency radio access, advanced antenna systems, flexible duplex schemes, D2D (Device-to-Device) connectivity, dynamic spectrum access, self-backhauling and network slicing
– Complementary concepts including NFV, SDN, hyperscale data centers, Cloud RAN, satellite communications and aerial networking platforms
– Case studies and review of mobile operator 5G commitments
– 5G standardization, development and research initiatives
– Analysis of spectrum availability and allocation strategies for 5G networks
– Competitive assessment of vendor strategies
– Review of investments on R&D and pre-standards 5G networks
– Standardized 5G infrastructure, user equipment and operator service forecasts till 2030

Forecast Segmentation
Market forecasts are provided for each of the following submarkets and their subcategories:

5G R&D Investments
– New Air Interface & Millimeter Wave Radio Access
– MIMO, Beamforming & Advanced Antenna Technologies
– Spectrum Sharing, Aggregation & Interference Management
– Virtualization & Cloud RAN
– Network Slicing & Other Technologies

Pre-Standards 5G Network Investments
– Pre-Standards Base Stations
– Pre-Standards User Equipment
– Transport Networking & Other Investments

Standardized 5G Infrastructure Investments
– 5G NR (New Radio)
 Distributed Macrocell Base Stations
 Small Cells
 RRHs (Remote Radio Heads)
 C-RAN BBUs (Baseband Units)
– NextGen (Next Generation) Core Network
– Fronthaul & Backhaul Networking

Standardized 5G User Equipment Investments
– Handsets
– Tablets
– Embedded IoT Modules
– USB Dongles
– Routers

5G Operator Services
– Subscriptions
– Service Revenue

Regional Segmentation
– Asia Pacific
– Eastern Europe
– Latin & Central America
– Middle East & Africa
– North America
– Western Europe

Key Questions Answered
The report provides answers to the following key questions:
– How big is the opportunity for 5G network infrastructure, user equipment and operator services?
– What trends, challenges and barriers will influence the development and adoption of 5G?
– How will 5G drive the adoption of AR (Augmented Reality)/VR (Virtual Reality) applications such as 3D holographic telepresence and 360 degree streaming of live events?
– How have advanced antenna and chip technologies made it possible to utilize millimeter wave spectrum for mobile communications in 5G networks?
– How can non-orthogonal multiple access schemes such as RSMA (Resource Spread Multiple Access) enable 5G networks to support higher connection densities for Millions of IoT devices?
– What will be the number of 5G subscriptions in 2019 and at what rate will it grow?
– Which regions and countries will be the first to adopt 5G?
– Which frequency bands are most likely to be utilized by 5G networks?
– Who are the key 5G vendors and what are their strategies?
– Will 5G networks rely on a disaggregated RAN architecture?
– How will 5G impact the fiber industry?
– Will satellite communications and aerial networking platforms play a wider role in 5G networks?

Key Findings
The report has the following key findings:
– The Unites States and South Korea are spearheading early investments in pre-standards 5G trial networks, as mobile operators rush to be the first to offer 5G networks. SNS Research estimates that by the end of 2017, pre-standards 5G network investments are expected to account for over $250 Million.
– Following completion of the 3GPP’s first phase of 5G specifications in March 2018, SNS Research expects that early adopters across the globe will simultaneously begin commercializing 5G services in 2019.
– Between 2019 and 2025, we expect the 5G network infrastructure market to aggressively grow at a CAGR of nearly 70%, eventually accounting for $28 Billion in annual spending by the end of 2025.
– Although early 5G R&D investments have primarily targeted the radio access segment, network-slicing has recently emerged as necessary “end-to-end” capability to guarantee performance for different 5G applications which may have contrasting requirements.
– In order to support diverse usage scenarios, 5G networks are expected to utilize a variety of frequency bands ranging from established sub-6 GHz cellular bands to millimeter wave spectrum.

The post The 5G Wireless Ecosystem: 2017 – 2030 first appeared on CRI Report.

Key Players
The major players operating in this market, who have adopted these strategies are International Paper Company (U.S.), Mondi Group (U.S.), Packaging Corporation of America (U.S.), Klabin S.A. (Brazil), Georgia Pacific LLC (U.K.), DS Smith Plc. (U.K.), Smurfit Kappa Group (Ireland), Nippon Paper Industries (Japan), Rengo Co. Ltd (Japan), Orora Packaging Australia Pty Ltd (Australia) and others.

Objective of Global Retail E-commerce Packaging Market Analysis & Forecast, from 2016 to 2022
• To provide detailed analysis of the market structure along with forecast for the next ten years of the various segments and sub-segments included in global retail e-commerce packaging market with analysis of its development and demand in the market
• High growth geographies and countries were identified
• Regional and country specific demand and forecast for global retail e-commerce packaging were studied
• Key segments covered in the report are: material and application.
• Unit breakdown for all different classification was finalized; and same was referred for forecasting, keeping few assumptions into factor
• For all the regions, forecast demand for all applications were identified and then with historical figure, data collected through primary and annual reports were triangulated to derive the regional market size
• Historical trend is identified to forecast and estimate the future value data

Target Audience
• Manufactures
• Raw materials suppliers
• Aftermarket suppliers
• Research institute & education institute
• Potential investors
• Key executive (CEO and COO) and strategy growth manager

Key Findings
• The Global Retail E-commerce Packaging market is expected to reach USD 21,669.7 million by 2022.
• By material, Protective packaging in global retail e-commerce packaging accounts for the largest market share and is growing with approximately ~6.25% CAGR during forecast period.
• By Application, electronics & consumer goods segment holds the largest market growing with approximately 6.15% CAGR by the end of forecast period.
• Geographically, Asia-Pacific region has been projected to have the largest market share in global Retail E-commerce packaging market followed by Europe region.
Regional and Country Analysis of Global Retail E-commerce Packaging Market Estimation and Forecast
The global retail e-commerce packaging market is expected to grow at a promising rate during the forecast period, 2016-2022. Asia-Pacific is projected to have the largest market in global retail E-commerce Packaging market. Increase in online shopping market, growing demand of packaged food and Rapid growth in electronic sector is driving market in Asia-Pacific region. Followed by Europe region would hold a large share in the market.
The reports also cover country level analysis:
• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Spain
o Rest of the Europe
• Asia – Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
• Rest of the World

Table of Contents

1 Executive Summary 13
2 Introduction 15
2.1 Definition 15
2.2 Scope of the Study 15
2.3 Assumptions 15
2.4 Market Structure 16
3 Research Methodology 17
3.1 Research Process 17
3.2 Primary Research 18
3.3 Secondary Research 18
3.4 Market Size Estimation 18
3.5 Forecast Model 20
4 Market Dynamics 21
4.1 Drivers 22
4.1.1 Increase in online shopping market 22
4.1.2 Growing demand of packaged food 22
4.1.3 Rapid growth in electronic sector 23
4.2 Restraints 24
4.2.1 Government regulation for corrugated packaging 24
4.2.2 Increase in environment safety 24
4.3 Opportunity 24
4.3.1 Growing demand for protective packaging 24
4.3.2 Increase in Disposable income of developing countries 24
5 Market Factor Analysis 26
5.1 Porter’s 5 Forces Analysis 26
5.1.1 Threat of New Entrants 26
5.1.2 Bargaining Power of Suppliers 26
5.1.3 Bargaining Power of Buyers 27
5.1.4 Threat of Substitutes 27
5.1.5 Rivalry 27
5.2 Value Chain Analysis 27
6 Global Retail E-commerce Packaging Market, By Material 29
6.1 Overview 30
6.1.1 Protective Packaging 31
6.1.2 Corrugated Boxes 32
6.1.3 Security Envelopes 32
6.1.4 Tapes & labels 32
6.1.5 Others 32
7 Global Retail E-commerce Packaging Market, By Application 33
7.1 Overview 34
7.1.1 Electronics & Consumer goods 36
7.1.2 Apparel & Accessories 36
7.1.3 Home furnishing 36
7.1.4 Auto Parts 36
7.1.5 Food & Beverages 36
7.1.6 Healthcare & Personal Care 36
7.1.7 Others 37
8 Retail E-commerce Packaging Market, By Region 38
8.1 Introduction 39
8.2 North America 40
8.2.1 U.S. 43
8.2.2 Canada 46
8.3 Europe 48
8.3.1 Germany 51
8.3.2 U.K. 53
8.3.3 France 55
8.3.4 Spain 57
8.3.5 Rest of Europe 59
8.4 Asia-Pacific 61
8.4.1 China 64
8.4.2 Japan 66
8.4.3 India 68
8.4.4 Rest of Asia-Pacific 70
8.5 Rest of the World 72
8.5.1 Middle East & Africa 75
8.5.2 South America 77
9 Competitive Scenario 80
9.1 Overview 80
9.1.1 Merger and Acquisition 81
9.1.2 Expansion 81
9.1.3 Partnership and Collaboration – 2014-2016 (In %) 83
9.1.4 New Product 83
10 Company Profiles 85
10.1 International Paper Company 85
10.1.1 Company Overview 85
10.1.2 Financial Overview 85
10.1.3 Product/Service Offering 86
10.1.4 Strategy 86
10.1.5 INTERNATIONAL PAPER COMPANY: SWOT Analysis 87
10.2 Mondi Group 88
10.2.1 Company Overview 88
10.2.2 Financial Overview 88
10.2.3 Product/Service Offering 89
10.2.4 Strategy 89
10.2.5 MONDI GROUP: SWOT Analysis 90
10.3 DS Smith Plc. 91
10.3.1 Company Overview 91
10.3.2 Financial Overview 91
10.3.3 Product/Service Offering 92
10.3.4 Strategy 92
10.3.5 D.S Smith: Swot Analysis 93
10.4 Packaging Corporation of America 94
10.4.1 Company Overview 94
10.4.2 Financial Overview 94
10.4.3 Product/Service Offering 95
10.4.4 Strategy 95
10.4.5 PACKAGING CORPORATION OF AMERICA: SWOT Analysis 96
10.5 Rengo Co. Ltd 97
10.5.1 Company Overview 97
10.5.2 Financial Overview 97
10.5.3 Product/Service Offering 98
10.5.4 Strategy 98
10.5.5 Rengo Co. Ltd: SWOT Analysis 99
10.6 Klabin S.A. 100
10.6.1 Company Overview 100
10.6.2 Financial Overview 100
10.6.3 Product/Service Offering 101
10.6.4 Strategy 101
10.6.5 klabin S.A.: SWOT Analysis 102
10.7 Nippon Paper Industries Co. Ltd. 103
10.7.1 Company Overview 103
10.7.2 Financial Overview 103
10.7.3 Product/Service Offering 104
10.7.4 Strategy 104
10.7.5 NIPPON PAPER INDUSTRIES CO. LTD.: SWOT Analysis 105
10.8 Georgia-Pacific LLC 106
10.8.1 Company Overview 106
10.8.2 Financial Overview 106
10.8.3 Product/Service Offering 106
10.8.4 Strategy 107
10.8.5 Georgia-Pacific LLC: SWOT Analysis 108
10.9 Orora Packaging Australia Pty Ltd. 109
10.9.1 Company Overview 109
10.9.2 Financial Overview 109
10.9.3 Product/Service Offering 110
10.9.4 Strategy 110
10.9.5 Orora Packaging: SWOT Analysis 111
10.10 Smurfit Kappa Group 112
10.10.1 Company Overview 112
10.10.2 Financial Overview 112
10.10.3 Product/Service Offering 113
10.10.4 Strategy 113
10.10.5 Smurfit Kappa Group: SWOT Analysis 114

List of Tables

TABLE 1 MARKET SYNOPSIS 14
TABLE 2 GDP PER CAPITA IN DEVELOPING NATIONS (USD) 25
TABLE 3 GLOBAL RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 31
TABLE 4 GLOBAL RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 35
TABLE 5 GLOBAL RETAIL E-COMMERCE PACKAGING MARKET, BY REGION, 2014-2022 (USD MILLION) 40
TABLE 6 NORTH AMERICA: RETAIL E-COMMERCE PACKAGING MARKET, BY COUNTRY, 2014-2022 (USD MILLION) 41
TABLE 7 NORTH AMERICA: RETAIL E-COMMERCE MARKET SIZE, BY MATERIAL, 2014-2022 (USD MILLION) 42
TABLE 8 NORTH AMERICA: RETAIL E-COMMERCE MARKET SIZE, BY APPLICATION, 2014-2022 (USD MILLION) 43
TABLE 9 U.S.: RETAIL E-COMMERCE MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 44
TABLE 10 U.S.: RETAIL E-COMMERCE MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 45
TABLE 11 CANADA: RETAIL E-COMMERCE MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 46
TABLE 12 CANADA: RETAIL E-COMMERCE MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 47
TABLE 13 EUROPE: RETAIL E-COMMERCE MARKET, BY COUNTRY, 2014-2022 (USD MILLION) 48
TABLE 14 EUROPE: RETAIL E-COMMERCE MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 49
TABLE 15 EUROPE: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 50
TABLE 16 GERMANY: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 51
TABLE 17 GERMANY: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 52
TABLE 18 U.K.: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 53
TABLE 19 U.K.: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 54
TABLE 20 FRANCE: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 55
TABLE 21 FRANCE: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 56
TABLE 22 SPAIN: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 57
TABLE 23 SPAIN: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 58
TABLE 24 REST OF EUROPE RETAIL: E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 59
TABLE 25 REST OF EUROPE: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 60
TABLE 26 ASIA-PACIFIC: RETAIL E-COMMERCE PACKAGING MARKET, BY COUNTRY, 2014-2022 (USD MILLION) 61
TABLE 27 ASIA-PACIFIC: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 62
TABLE 28 ASIA-PACIFIC: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 63
TABLE 29 CHINA: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 64
TABLE 30 CHINA: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 65
TABLE 31 JAPAN: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 66
TABLE 32 JAPAN: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 67
TABLE 33 INDIA: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 68
TABLE 34 INDIA: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 69
TABLE 35 REST OF ASIA-PACIFIC: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 70
TABLE 36 REST OF ASIA-PACIFIC: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 70
TABLE 37 REST OF ASIA-PACIFIC: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 71
TABLE 38 ROW: RETAIL E-COMMERCE PACKAGING MARKET, BY COUNTRY, 2014-2022 (USD MILLION) 72
TABLE 39 ROW: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 73
TABLE 40 ROW: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 74
TABLE 41 MIDDLE EAST & AFRICA: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 75
TABLE 42 MIDDLE EAST & AFRICA: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 76
TABLE 43 SOUTH AMERICA: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 77
TABLE 44 SOUTH AMERICA: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 78

List of Figures

FIGURE 1 RESEARCH PROCESS OF MRFR 17
FIGURE 2 TOP DOWN & BOTTOM UP APPROACH 19
FIGURE 3 DRIVERS & RESTRAINTS IMPACT ANALYSIS OF GLOBAL RETAIL E-COMMERCE PACKAGING MARKET 21
FIGURE 4 TOTAL REVENUE COMPARISON BETWEEN AMAZON & EBAY, 2013-2015 (USD MILLION) 22
FIGURE 5 GLOBAL BEVERAGE MARKET SALE, 2007-2017, (MILLION LITRES) 23
FIGURE 6 GLOBAL PRODUCTION OF ELECTRONICS, 2012 (USD MILLION) 23
FIGURE 7 PORTER’S 5 FORCES ANALYSIS OF GLOBAL RETAIL E-COMMERCE PACKAGING MARKET 26
FIGURE 8 GLOBAL RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2015 (IN %) 30
FIGURE 9 GLOBAL RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014 TO 2022 (USD MILLION) 31
FIGURE 10 GLOBAL RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2015 (%) 34
FIGURE 11 GLOBAL RETAIL E-COMMERCE MARKET, BY APPLICATION, 2014 TO 2022 (USD MILLION) 35
FIGURE 12 GLOBAL RETAIL E-COMMERCE PACKAGING MARKET, BY REGION, 2014 TO 2022 (USD MILLION) 39
FIGURE 13 NORTH AMERICA: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY COUNTRY, 2015 (% SHARE) 40
FIGURE 14 NORTH AMERICA: RETAIL E-COMMERCE PACKAGING MARKET SIZE, BY MATERIAL, 2014-2022 (USD MILLION) 41
FIGURE 15 NORTH AMERICA: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY APPLICATION, 2015 (% SHARE) 42
FIGURE 16 U.S.: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 44
FIGURE 17 U.S.: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY APPLICATION, 2015 (% SHARE) 45
FIGURE 18 CANADA: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 46
FIGURE 19 CANADA: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY APPLICATION, 2015 (% SHARE) 47
FIGURE 20 EUROPE: RETAIL E-COMMERCE PACKAGING MARKET, BY REGION, 2014 TO 2022 (USD MILLION) 48
FIGURE 21 EUROPE: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 49
FIGURE 22 EUROPE: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY APPLICATION, 2015 (% SHARE) 50
FIGURE 23 GERMANY: RETAIL E-COMMERCE PACKAGING MARKET, BY REGION, 2014-2022 (USD MILLION) 51
FIGURE 24 GERMANY: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY APPLICATION, 2015 (% SHARE) 52
FIGURE 25 U.K.: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 53
FIGURE 26 U.K.: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY APPLICATION, 2015 (% SHARE) 54
FIGURE 27 FRANCE: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 55
FIGURE 28 FRANCE: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY APPLICATION, 2015 (% SHARE) 56
FIGURE 29 SPAIN: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 57
FIGURE 30 SPIAN: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY APPLICATION, 2015 (% SHARE) 58
FIGURE 31 REST OF EUROPE: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY MATERIAL, 2015 (IN %) 59
FIGURE 32 REST OF EUROPE: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014 TO 2022 (USD MILLION) 60
FIGURE 33 ASIA-PACIFIC: RETAIL E-COMMERCE PACKAGING MARKET, BY COUNTRY, 2014 TO 2022 (USD MILLION) 61
FIGURE 34 ASIA-PACIFIC: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014- 2022 (USD MILLION) 62
FIGURE 35 ASIA-PACIFIC: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY APPLICATION, 2014-2022(USD MILLION) 63
FIGURE 36 CHINA: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014- 2022 (USD MILLION) 64
FIGURE 37 CHINA: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014 -2022 (USD MILLION) 65
FIGURE 38 JAPAN: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014- 2022 (USD MILLION) 66
FIGURE 39 JAPAN: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY APPLICATION, 2015 (IN % ) 67
FIGURE 40 INDIA: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY MATERIAL, 2015 (IN %) 68
FIGURE 41 INDIA: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2014-2022 (USD MILLION) 69
FIGURE 42 REST OF ASIA-PACIFIC: RETAIL E-COMMERCE PACKAGING MARKET SHARE, BY APPLICATION, 2015 (USD MILLION) 71
FIGURE 43 ROW: RETAIL E-COMMERCE PACKAGING MARKET, BY COUNTRY, 2014-2022 (USD MILLION) 72
FIGURE 44 ROW: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (IN %) 73
FIGURE 45 ROW: RETAIL E-COMMERCE PACKAGING MARKET SIZE, BY APPLICATION, 2015 (IN %) 74
FIGURE 46 MIDDLE EAST & AFRICA: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 75
FIGURE 47 MIDDLE EAST & AFRICA: RETAIL E-COMMERCE PACKAGING MARKET, BY COUNTRY, 2015 (IN %) 76
FIGURE 48 SOUTH AMERICA: RETAIL E-COMMERCE PACKAGING MARKET, BY MATERIAL, 2014-2022 (USD MILLION) 77
FIGURE 49 SOUTH AMERICA: RETAIL E-COMMERCE PACKAGING MARKET, BY APPLICATION, 2015 (IN %) 78
FIGURE 50 GROWTH STRATEGIES ADOPTED BY KEY PLAYERS IN GLOBAL RETAIL E-COMMERCE PACKAGING MARKET, 2014-2016, (IN %) 80
FIGURE 51 MERGER AND ACQUISITION: % SHARE BY KEY PLAYERS, 2014-2016, (IN %) 81
FIGURE 52 EXPANSION: % SHARE BY KEY PLAYERS, 2014-2016, (IN %) 81
FIGURE 53 PARTNERSHIP AND COLLABORATION: % SHARE BY KEY PLAYERS, 2014-2016, (IN %) 83
FIGURE 54 NEW PRODUCT: % SHARE BY KEY PLAYERS, 2014-2016, (IN %) 83
FIGURE 55 INTERNATIONAL PAPER COMPANY.: TOTAL REVENUE VS SEGMENTAL REVENUE (USD MILLION) 85
FIGURE 56 INTERNATIONAL PAPER COMPANY: GEOGRAPHIC REVENUE MIX, 2016 (%) 86
FIGURE 57 INTERNATIONAL PAPER COMPANY: KEY DEVELOPMENTS, 2013-2016 (%) 87
FIGURE 58 MONDI GROUP: TOTAL REVENUE VS SEGMENTAL REVENUE (USD MILLION) 88
FIGURE 59 MONDI GROUP: GEOGRAPHIC REVENUE MIX, 2016 (%) 89
FIGURE 60 MONDI GROUP: KEY DEVELOPMENTS, 2013-2016 (%) 90
FIGURE 61 DS SMITH.: TOTAL REVENUE VS SEGMENTAL REVENUE (USD MILLION) 91
FIGURE 62 DS SMITH.: GEOGRAPHIC REVENUE MIX, 2016 (%) 92
FIGURE 63 D.S SMITH: KEY DEVELOPMENTS, 2013-2016 (%) 93
FIGURE 64 PACKAGING CORPORATION OF AMERICA.: TOTAL REVENUE VS SEGMENTAL REVENUE (USD MILLION) 94
FIGURE 65 PACKAGING CORPORATION OF AMERICA: GEOGRAPHIC REVENUE MIX, 2016 (%) 95
FIGURE 66 PACKAGING CORPORATION OF AMERICA: KEY DEVEOPMENTS, 2013-2016 (%) 96
FIGURE 67 RENGO CO. LTD: TOTAL REVENUE VS SEGMENTAL REVENUE (USD MILLION) 97
FIGURE 68 RENGO CO. LTD: KEY DEVELOPMENTS, 2014-2016 (%) 98
FIGURE 69 KLABIN S.A.: TOTAL REVENUE VS SEGMENTAL REVENUE (USD MILLION) 100
FIGURE 70 KLABIN S.A.: GEOGRAPHIC REVENUE MIX, 2016 (%) 101
FIGURE 71 KLABIN S.A.: KEY DEVEOPMENTS, 2013-2016 (%) 102
FIGURE 72 NIPPON PAPER INDUSTRIES CO. LTD.: TOTAL REVENUE VS SEGMENTAL REVENUE (USD MILLION) 103
FIGURE 73 NIPPON PAPER INDUSTRIES CO. LTD.: KEY DEVEOPMENTS, 2014-2017 (%) 104
FIGURE 74 ORORA PACKAGING: TOTAL REVENUE VS SEGMENTAL REVENUE (USD MILLION) 109
FIGURE 75 ORORA PACKAGING: GEOGRAPHIC REVENUE MIX, 2016 (%) 110
FIGURE 76 ORORA PACKAGING: KEY DEVELOPMENTS, 2014-2017 (%) 111
FIGURE 77 SMURFIT KAPPA GROUP: TOTAL REVENUE, 2013 TO 2015 (USD MILLION) 112
FIGURE 78 SMURFIT KAPPA GROUP: GEOGRAPHIC REVENUE MIX, 2015 (%) 113
FIGURE 79 SMURFIT KAPPA GROUP: KEY DEVELOPMENTS, 2014-2017 (%) 114

The post Global Retail E-commerce Packaging Market – Trends & Forecast, 2016-2022 first appeared on CRI Report.

Study objectives of IV solutions market
• To provide insights about factors influencing and affecting the market growth.
• To provide historical and forecast revenues of the market segments and sub-segments with respect to regional and country-level markets.
• To provide historical and forecast revenue of the market segments based on types, applications, samples, end users, and its sub-segments.
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

Target Audience
• Global Liquid Biopsy manufacturers
• Global Liquid Biopsy suppliers
• Research and development Laboratories
• Market Research and Consulting Service Providers

Key findings
• Circulating tumor cells (CTCs) segment dominates both in terms of market share as well as revenues, contributing approx. 55.48 % of the revenue share of the liquid biopsy market.
• On the basis of the therapeutic application, the segment for Cancer will reflect the highest growth potential, with over 82.83% of the market share by revenues. However, the urine sample segment is anticipated to witness noticeable growth.
• The market for liquid biopsy is dominated by North America and Europe and this trend will continue. Asia-Pacific market is the fastest growing market and is expected to grow at a CAGR of 29.7% during forecasted period
Segments
Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centers and others.
Regional Analysis of Global Liquid Biopsy market
Globally North America is the largest market for Global Liquid Biopsy market. Europe is the second-largest market for Global Liquid Biopsy market. However the developing regions market particularly Asia Pacific will be the fastest growing and will be the key to the future. North America accounted for the largest market share of 37.95% in 2016 accounting for a market value of 1,499.10 million in 2016. Asia pacific is the fastest growing market which is growing at a CAGR of 28.8%.

1 Report Prologue 14
2 Introduction 15
2.1 Scope of Study 15
2.2 Research Objective 15
2.3 Assumptions & Limitations 15
2.3.1 Assumptions 15
2.3.2 Limitations 16
2.4 Market Structure 16
3 Research Methodology 17
3.1 Research Process 17
3.2 Primary Research 18
3.3 Secondary Research 18
4 Market Dynamics 19
4.1 Introduction 19
4.2 Drivers 19
4.2.1 Comparatively painless and non-invasive technique 19
4.2.2 Early real time high precision detection of diseases 19
4.2.3 Useful for designing effective treatment strategies based on the real time molecular assessment for the progression of the disease 19
4.2.4 Rise in cases of cancer and other diseases 20
4.2.5 Lifestyle changes and environmental factors 20
4.2.6 Other advantages over other techniques 20
4.2.7 The recent technological advancements has increased the appeal of liquid biopsy 20
4.2.8 Transferability of liquid biopsy 21
4.2.9 Rising investment in research and development and collaborations between companies and public organizations 21
4.2.10 Greater focus on venture capital 21
4.2.11 Demographical factors 21
4.3 Restraints 22
4.3.1 Prohibitive costs associated with liquid biopsy 22
4.3.2 Lower sensitivity for certain biomarkers 22
4.3.3 Not all cancers patients benefit from early detection 22
4.3.4 Liquid biopsy is not all non-invasive 22
4.3.5 Differential awareness and availability between developing and developed world 22
4.3.6 Issues in venture capital, startups and collaborations 23
4.4 Opportunities 23
4.4.1 Growing collaboration between companies has become the entrance gateway for new firms 23
4.4.2 Funding from public organizations is a good strategy to reduce development costs 23
4.4.3 Rise in research and development investment 23
4.4.4 Developing economies provide an unserved market for liquid biopsy 23
4.4.5 Growing trend of start-ups and venture investment in the field of liquid biopsy 24
4.5 Challenges 24
4.5.1 Information and interest gap between the investors and the developers 24
4.5.2 Lack of trained professionals in developing regions 24
4.5.3 Lack of standardization and transparency 24
5 Market Factor Analysis 26
5.1 Porter’s Five Force Analysis 26
5.1.1 Bargaining Power of Buyer 27
5.1.2 Bargaining Power of Supplier 28
5.1.3 Threat from substitute 28
5.1.4 Threat from a New Entrant 28
5.1.5 Intensity of Competitive Rivalry 28
5.2 Value Chain Analysis 29
5.2.1 Device Manufacturers 30
5.2.2 Software developers 30
5.2.3 Reagent and accessory suppliers 30
5.2.4 Healthcare providers 30
5.2.5 Patients 30
6 Liquid Biopsy Market, By Biomarker Types 31
6.1 Introduction 32
6.2 Circulating Tumor Cells (CTCs) 33
6.3 Circulating Tumour DNA (CtDNA) 34
6.4 Extracellular Vesicles (EVs) 35
6.5 Other biomarker (circulating RNA and proteins) 36
7 Global Liquid Biopsy Market by Application 38
7.1 Introduction 38
7.2 Cancer therapeutic application 39
7.3 Reproductive health 40
7.4 Other therapeutic application market 41
8 Global Liquid Biopsy Market by Sample 43
8.1 Introduction 43
8.2 Blood Sample market, by region, 2015 & 2022 ($ million) 44
8.3 Urine sample market, by region, 2015 & 2022 ($ million) 45
8.4 Other sample market, by region, 2015 & 2022 ($ million) 46
9 Global Liquid Biopsy Market by End User 48
9.1 Introduction 48
9.2 Hospitals and Laboratories End Users, By Region 49
9.3 Academic and Research Centres end users market 50
9.4 Other end users market 51
10 Global liquid Biopsy Market, by Region 53
10.1 Introduction 53
10.2 North North America 54
10.2.1 US 59
10.2.2 CANADA 63
10.3 EUROPE 67
10.3.1 Germany 72
10.3.2 France 76
10.3.3 U.K. 80
10.3.4 Italy 84
10.3.5 Spain 88
10.3.6 Rest of Europe 92
10.4 APEC 97
10.4.1 Japan 103
10.4.2 China 107
10.4.3 India 111
10.4.4 Australia 115
10.4.5 Korea 119
10.4.6 Rest of Asia Pacific 123
10.5 Middle East and Africa 127
10.5.1 UAE 132
10.5.2 Saudi Arabia 136
10.5.3 Egypt 140
10.5.4 Rest of Middle East and Africa 144
11 Company Profile 149
11.1 Guardant Health, Inc 149
11.1.1 Company Overview 149
11.1.2 Product/Business Segment Overview 149
11.1.3 Financial Overview 149
11.1.4 Key Development 150
11.1.5 SWOT Analysis 151
11.2 Trovagene, Inc 152
11.2.1 Company Overview 152
11.2.2 Product/Business Segment Overview 152
11.2.3 Financial Overview 152
11.2.4 SWOT Analysis 153
11.3 RainDance Technologies, Inc. 155
11.3.1 Company Overview 155
11.3.2 Product/Business Segment Overview 155
11.3.3 Financial Overview 155
11.3.4 Key Development 155
11.3.5 SWOT Analysis 156
11.4 Agena Bioscience Inc. Inc. 157
11.4.1 Company Overview 157
11.4.2 Product/Business Segment Overview 157
11.4.3 Financial Overview 157
11.4.4 Key Development 157
11.5 Admera Health 159
11.5.1 Company Overview 159
11.5.2 Product/Business Segment Overview 159
11.5.3 Financial Overview 159
11.5.4 Key Development 159
11.5.5 SWOT Analysis 159
11.6 Biocept, Inc. 161
11.6.1 Company Overview 161
11.6.2 Product/Business Segment Overview 161
11.6.3 Financial Overview 161
11.6.4 Key Development 161
11.7 Circulogene Theranostics 162
11.7.1 Company Overview 162
11.7.2 Financial Overview 162
11.7.3 Key Development 162
11.8 Inivata Ltd 163
11.8.1 Company Overview 163
11.8.2 Product/Business Segment Overview 163
11.8.3 Financial Overview 163
11.8.4 Key Development 163
11.9 SAGA Diagnostics AB 164
11.9.1 Company Overview 164
11.9.2 Product/Business Segment Overview 164
11.9.3 Financial Overview 164
11.9.4 Key Development 164
11.10 Exosome Diagnostics 165
11.10.1 Company Overview 165
11.10.2 Financial Overview 165
11.10.3 Key Development 165

TABLE 1 global LIQUID BIOPSY, Biomarker Types, 2014-2022 ($ million) 34
TABLE 2 CIRCULATING TUMOR CELLS (CTCS) market, by region, 2014-2022 ($ million) 35
TABLE 3 Circulating Tumor DNA (CtDNA) market, by region, 2014-2022 ($ million) 39
TABLE 4 Medical devices market, by region, 2014-2022 ($ million) 40
TABLE 5 wearable devices market, by region, 2014-2022 ($ million) 44
TABLE 6 Connected Drug Delivery Systems market, by region, 2014-2022 ($ million) 48
TABLE 7 EXTRACELLULAR VESICLES (EVS) market, by region, 2014-2022 ($ million) 51
TABLE 8 Global LIQUID BIOPSY Value, by Application, 2014-2022 (USD million) 54
TABLE 9 Monitoring Applications Market, by region, 2014-2022 (USD million) 55
TABLE 10 Diagnosis & Treatments Market, by region, 2014-2022 (USD million) 56
TABLE 11 Education & Awareness Market, by region, 2014-2022 ($ million) 57
TABLE 12 Healthcare Managements Market, by region, 2014-2022 ($ million) 58
TABLE 13 Wellness & Preventions Market, by region, 2014-2022 (USD million) 59
TABLE 14 Other Applications: Global LIQUID BIOPSY Value, by Geography, 2014-2022 (USD million) 60
TABLE 15 Global liquid biopsy Market, by Region, 2014-2022($ Million) 63
TABLE 16 North America LIQUID BIOPSY, By Country, 2014-2022 ($ million) 64
TABLE 17 North America LIQUID BIOPSY, Biomarker Types, 2014-2022 ($ million) 65
TABLE 18 North America LIQUID BIOPSY, BY APPLICATION, 2014-2022 ($ MILLION) 66
TABLE 19 North America liquid biopsy market, by application, 2014-2022 ($ million) 66
TABLE 20 U.S. liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 67
TABLE 21 U.S. liquid biopsy Market, By Application, 2014-2022 ($ million) 68
TABLE 22 Canada LIQUID BIOPSY, Biomarker Types, 2014-2022 ($ million) 69
TABLE 23 Canada LIQUID BIOPSY, By application, 2014-2022 ($ million) 69
TABLE 24 Europe LIQUID BIOPSY, By Country, 2014-2022 ($ million) 71
TABLE 25 Europe liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 72
TABLE 26 Europe LIQUID BIOPSY, By application, 2014-2022 ($ million) 73
TABLE 27 Germany liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 73
TABLE 28 Germany liquid biopsy Market, By application, 2014-2022 ($ million) 74
TABLE 29 France liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 74
TABLE 30 France liquid biopsy Market, By application, 2014-2022 ($ million) 75
TABLE 31 U.K. LIQUID BIOPSY, Biomarker Types, 2014-2022 ($ million) 75
TABLE 32 U.K. LIQUID BIOPSY, By application, 2014-2022 ($ million) 76
TABLE 33 Italy liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 76
TABLE 34 Italy LIQUID BIOPSY, By application, 2014-2022 ($ million) 77
TABLE 35 Spain liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 77
TABLE 36 Spain LIQUID BIOPSY, By application, 2014-2022 ($ million) 78
TABLE 37 Asia-Pacific LIQUID BIOPSY, By Country, 2014-2022 ($ million) 80
TABLE 38 Asia-Pacific liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 81
TABLE 39 Asia-Pacific liquid biopsy Market, By application, 2014-2022 ($ million) 82
TABLE 40 Japan liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 83
TABLE 41 Japan liquid biopsy Market, By application, 2014-2022 ($ million) 83
TABLE 42 China liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 84
TABLE 43 China liquid biopsy Market, By application, 2014-2022 ($ million) 85
TABLE 44 India liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 86
TABLE 45 India liquid biopsy Market, By application, 2014-2022 ($ million) 86
TABLE 46 Australia liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 87
TABLE 47 Australia liquid biopsy Market, By application, 2014-2022 ($ million) 88
TABLE 48 Republic of Korea liquid biopsy Market, Biomarker Types, 2014-2022 ($ million) 88
TABLE 49 Republic of Korea liquid biopsy Market, By application, 2014-2022 ($ million) 89
TABLE 50 Middle East & Africa LIQUID BIOPSY, By Region, 2014-2022 ($ million) 90
TABLE 51 Middle East & Africa LIQUID BIOPSY, Biomarker Types, 2014-2022 ($ million) 91
TABLE 52 Middle East & Africa LIQUID BIOPSY, By Application, 2014-2022 ($ million) 92
TABLE 53 Connected healthcare: Partnerships, Agreements, and collaborations 94
TABLE 54 Connected healthcare: Product development and launch 98
TABLE 55 Connected healthcare: Approvals 99
TABLE 56 Connected healthcare: acquisitions 101
TABLE 57 CONNECTED HEALTHCARE: AWARD & RECOGNITION 101
TABLE 58 CONNECTED HEALTHCARE: Others 102
TABLE 59 Agamatrix, Inc.: Key Development 104
TABLE 60 AirStrip Technologies: Key Development 106
TABLE 61 AliveCor Inc.: Key Development 108
TABLE 62 ALLSCRIPTS: Key Development 112
TABLE 63 ATHENAHEALTH, INC.: Key Development 117
TABLE 64 BOSTON SCIENTIFIC CORPORATION: Key Development 119
TABLE 65 Cerner: Key Development 122
TABLE 66 GE HEALTHCARE: Key Development 126
TABLE 67 HONEYWELL LIFE CARE SOLUTIONS: Key Development 129
TABLE 68 Medtronics: Key Development 131
TABLE 69 Persistent Systems: Key Development 137
TABLE 70 Koninklijke Philips N.V.: Key Development 140
TABLE 71 Qualcomm: Key Development 143
TABLE 72 Sanofi: Key Development 146

FIGURE 1 Global Liquid Biopsy: Market Structure 17
FIGURE 2 Research Process of MRFR 18
FIGURE 3 Global LIQUID BIOPSY: Porter five forces analysis 27
FIGURE 4 Global liquid biopsy market, by BIOMARKER TYPE, Market share 2016 (%) 32
FIGURE 5 GLOBAL LIQUID BIOPSY MARKET BY BIOMARKER TYPE, $ MILLION 2016 33
FIGURE 6 Circulating Tumor Cells (CTCs) market, by region, 2016, $ mILLION 34
FIGURE 7 Circulating tumor DNA (CtDNA) market, by region, 2016, $ million 35
FIGURE 8 Extracellular vesicles (EVS) market, by region, 2016 $ million 36
FIGURE 9 Other biomarker type market, by region, 2016, $ million 36
FIGURE 10 Global liquid biopsy market, by Therapeutic applications, Market share 2016 (%) 39
FIGURE 11 GLOBAL LIQUID BIOPSY MARKET BY Therapeutic applications, 2016, $ million 39
FIGURE 12 Cancer therapeutic application market, by region, 2014-2022 ($ million) 39
FIGURE 13 Cancer therapeutic application market, by region, 2016, $ million 40
FIGURE 14 Reproductive health therapeutic application market, by region, 2016, $ million 41
FIGURE 15 Other therapeutic application market, by region, 2016, $ million 41
FIGURE 16 Global liquid biopsy market, by Sample, Market share 2016 (%) 43
FIGURE 17 Global Liquid Biopsy Market by Sample, 2016, $ million 44
FIGURE 18 Blood Sample market, by region, 2016, $ million 45
FIGURE 19 Urine sample market, by region, 2016, $ million 45
FIGURE 20 Other sample market, by region, 2016, $ million 46
FIGURE 21 Global liquid biopsy market, by End User, Market share 2016 (%) 48
FIGURE 22 Global Liquid Biopsy Market by End User, 2016, $ million 49
FIGURE 23 Hospitals and Laboratories end users market by End User, 2016, $ million 49
FIGURE 24 Academic and Research Centers end users market, by End User, 2016, $ million 50
FIGURE 25 Other end users market, by End User, 2016, $ million 51
FIGURE 26 Global liquid biopsy market, by region, Market share 2016 (%) 53
FIGURE 27 Global liquid biopsy market, by region, 2014-2022 ($ million) 53
FIGURE 28 North AmericaNorth America liquid biopsy market, by COUNTRY, Market share 2016 (%) 54
FIGURE 29 North AmericaNorth America liquid biopsy market, by biomarker type, 2014-2022 ($ million) 55
FIGURE 30 North AmericaNorth America liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 56
FIGURE 31 North AmericaNorth America liquid biopsy market by sample type, 2014-2022 ($ million) 57
FIGURE 32 North AmericaNorth America liquid biopsy market by End users, 2014-2022 ($ million) 58
FIGURE 33 U.S. liquid biopsy market by biomarker type, 2014-2022 ($ million) 59
FIGURE 34 U.S. liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 60
FIGURE 35 U.S. liquid biopsy market by sample type, 2014-2022 ($ million) 61
FIGURE 36 U.S. liquid biopsy market by End users, 2014-2022 ($ million) 62
FIGURE 37 Canada liquid biopsy market by biomarker type, 2014-2022 ($ million) 63
FIGURE 38 Canada liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 64
FIGURE 39 Canada liquid biopsy market by sample type, 2014-2022 ($ million) 65
FIGURE 40 Canada liquid biopsy market by End users 66
FIGURE 41 Europe liquid biopsy market By Country, Market share 2016 (%) 67
FIGURE 42 Europe liquid biopsy market By Country, 2014-2022 ($ million) 68
FIGURE 43 Europe liquid biopsy market by biomarker type, 2014-2022 ($ million) 69
FIGURE 44 Europe liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 70
FIGURE 45 Europe liquid biopsy market by sample type, 2014-2022 ($ million) 71
FIGURE 46 Europe liquid biopsy market by End users, 2014-2022 ($ million) 72
FIGURE 47 Germany liquid biopsy market by biomarker type, 2014-2022 ($ million) 73
FIGURE 48 Germany liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 74
FIGURE 49 Germany liquid biopsy market by sample type, 2014-2022 ($ million) 75
FIGURE 50 Germany liquid biopsy market by End users, 2014-2022 ($ million) 75
FIGURE 51 France liquid biopsy market by biomarker type, 2014-2022 ($ million) 76
FIGURE 52 France liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 77
FIGURE 53 France liquid biopsy market by sample type, 2014-2022 ($ million) 78
FIGURE 54 France liquid biopsy market by End users, 2014-2022 ($ million) 79
FIGURE 55 U.K. liquid biopsy market by biomarker type, 2014-2022 ($ million) 80
FIGURE 56 U.K. liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 81
FIGURE 57 U.K. liquid biopsy market by sample type, 2014-2022 ($ million) 82
FIGURE 58 U.K. liquid biopsy market by End users, 2014-2022 ($ million) 83
FIGURE 59 Italy liquid biopsy market by biomarker type, 2014-2022 ($ million) 84
FIGURE 60 Italy liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 85
FIGURE 61 Italy liquid biopsy market by sample type, 2014-2022 ($ million) 86
FIGURE 62 Italy liquid biopsy market by End users, 2014-2022 ($ million) 87
FIGURE 63 Spain liquid biopsy market by biomarker type, 2014-2022 ($ million) 88
FIGURE 64 Spain liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 89
FIGURE 65 Spain liquid biopsy market by sample type, 2014-2022 ($ million) 90
FIGURE 66 Spain liquid biopsy market by End users, 2014-2022 ($ million) 91
FIGURE 67 Rest of Europe liquid biopsy market by biomarker type, 2014-2022 ($ million) 92
FIGURE 68 Rest of Europe liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 93
FIGURE 69 Rest of Europe liquid biopsy market by sample type, 2014-2022 ($ million) 94
FIGURE 70 Rest of Europe liquid biopsy market by End users, 2014-2022 ($ million) 95
FIGURE 71 APEC liquid biopsy market By Country, Market share 2016 (%) 97
FIGURE 72 APEC liquid biopsy market by country, 2014-2022 ($ million) 99
FIGURE 73 APEC liquid biopsy market by biomarker type, 2014-2022 ($ million) 100
FIGURE 74 Asia Pacific liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 101
FIGURE 75 Asia Pacific liquid biopsy market by sample type, 2014-2022 ($ million) 102
FIGURE 76 Asia Pacific liquid biopsy market by End users, 2014-2022 ($ million) 103
FIGURE 77 Japan liquid biopsy market by biomarker type, 2014-2022 ($ million) 104
FIGURE 78 Japan liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 104
FIGURE 79 Japan liquid biopsy market by sample type, 2014-2022 ($ million) 105
FIGURE 80 Japan liquid biopsy market by End users, 2014-2022 ($ million) 106
FIGURE 81 China liquid biopsy market by biomarker type, 2014-2022 ($ million) 107
FIGURE 82 China liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 108
FIGURE 83 China liquid biopsy market by sample type, 2014-2022 ($ million) 109
FIGURE 84 China liquid biopsy market by End users, 2014-2022 ($ million) 110
FIGURE 85 India liquid biopsy market by biomarker type, 2014-2022 ($ million) 111
FIGURE 86 India liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 112
FIGURE 87 India liquid biopsy market by sample type, 2014-2022 ($ million) 113
FIGURE 88 India liquid biopsy market by End users, 2014-2022 ($ million) 114
FIGURE 89 Australia liquid biopsy market by biomarker type, 2014-2022 ($ million) 115
FIGURE 90 Australia liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 116
FIGURE 91 Australia liquid biopsy market by sample type, 2014-2022 ($ million) 117
FIGURE 92 Australia liquid biopsy market by sample type, 2014-2022 ($ million) 117
FIGURE 93 Australia liquid biopsy market by End users, 2014-2022 ($ million) 118
FIGURE 94 Republic of Korea liquid biopsy market by biomarker type, 2014-2022 ($ million) 119
FIGURE 95 Republic of Korea liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 120
FIGURE 96 Republic of Korea liquid biopsy market by sample type, 2014-2022 ($ million) 121
FIGURE 97 Republic of Korea liquid biopsy market by End users, 2014-2022 ($ million) 122
FIGURE 98 Rest of Asia Pacific liquid biopsy market by biomarker type, 2014-2022 ($ million) 123
FIGURE 99 Rest of Asia Pacific liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 124
FIGURE 100 Rest of Asia Pacific liquid biopsy market by sample type, 2014-2022 ($ million) 125
FIGURE 101 Rest of Asia Pacific liquid biopsy market by End users, 2014-2022 ($ million) 126
FIGURE 102 Middle East and Africa liquid biopsy market, Market share By Country, 2016 (%) 127
FIGURE 103 Middle East and Africa liquid biopsy market By Country, 2014-2022 ($ million) 128
FIGURE 104 Middle East and Africa liquid biopsy market by biomarker type, 2014-2022 ($ million) 129
FIGURE 105 Middle East and Africa liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 130
FIGURE 106 Middle East and Africa liquid biopsy market by sample type, 2014-2022 ($ million) 131
FIGURE 107 Middle East and Africa liquid biopsy market by End users, 2014-2022 ($ million) 132
FIGURE 108 UAE liquid biopsy market by biomarker type, 2014-2022 ($ million) 132
FIGURE 109 UAE liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 133
FIGURE 110 UAE liquid biopsy market by sample type, 2014-2022 ($ million) 134
FIGURE 111 UAE liquid biopsy market by End users, 2014-2022 ($ million) 135
FIGURE 112 Saudi Arabia liquid biopsy market by biomarker type, 2014-2022 ($ million) 137
FIGURE 113 Saudi Arabia liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 137
FIGURE 114 Saudi Arabia liquid biopsy market by sample type, 2014-2022 ($ million) 138
FIGURE 115 Saudi Arabia liquid biopsy market by End users, 2014-2022 ($ million) 139
FIGURE 116 Egypt liquid biopsy market by biomarker type, 2014-2022 ($ million) 140
FIGURE 117 Egypt liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 141
FIGURE 118 Egypt liquid biopsy market by sample type, 2014-2022 ($ million) 142
FIGURE 119 Egypt liquid biopsy market by End users, 2014-2022 ($ million) 143
FIGURE 120 Rest of Middle East and Africa liquid biopsy market by biomarker type, 2014-2022 ($ million) 144
FIGURE 121 Rest of Middle East and Africa liquid biopsy market by therapeutic applications, 2014-2022 ($ million) 145
FIGURE 122 Rest of Middle East and Africa liquid biopsy market by sample type, 2014-2022 ($ million) 146
FIGURE 123 Rest of Middle East and Africa liquid biopsy market by End users, 2014-2022 ($ million) 147
FIGURE 124 Guardant Health, Inc: SWOT ANALYSIS 151
FIGURE 126 Trovagene, Inc Corporation: SWOT ANALYSIS 155
FIGURE 1 RAINDANCE: RECENT FINANCIAL 157
FIGURE 2 RainDance Technologies: SWOT ANALYSIS 158
FIGURE 3 Admera Health: SWOT ANALYSIS 159
FIGURE 4 BIOCEPT, INC.: SWOT ANALYSIS 161
FIGURE 5 CIRCULOGENE THERANOSTICS: SWOT ANALYSIS 163
FIGURE 6 SAGA DIAGNOSTICS AB: SWOT ANALYSIS 165
FIGURE 7 AGENA BIOSCIENCE INC.: SWOT ANALYSIS 167
FIGURE 8 Exosome Diagnostics: SWOT ANALYSIS 170

The post Global Liquid Biopsy Market Analysis & Forecast 2016 To 2022 first appeared on CRI Report.

1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Drivers
4.1.1 Improving Medical Device Regulation
4.1.2 Growing incidence number of contagious and non-contagious diseases
4.1.3 Increasing prevalence of diabetes
4.1.4 Increasing inclination towards home healthcare
4.2 Restrains
4.2.1 Risk Associated with blood transfusion
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining power of suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Supply Chain Analysis
6 Global Lancet Market, By Type
6.1 Safety lancet
6.3 Personal Lancet
7 Global Lancet Market, By End Users
7.1 Hospitals & Clinics
7.2 Diagnostic Centers and Pathology Laboratories
7.3 Home Diagnostics
7.4 Others
8 Global Lancet Market, By Regions
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 Middle East & Africa
9 Competitive Landscape
9.1 Pricing of Lancets
9.2 Production Capacity of Major Players
10 Company Profile
10.1 F. Hoffmann-La Roche AG
10.1.1 Overview
10.1.2 Product/Business Segment Overview
10.1.3 Financial Updates
10.1.4 Key Developments
10.2 Becton, Dickinson and Company
10.2.1 Overview
10.2.2 Product/Business Segment Overview
10.2.3 Financial Updates
10.2.4 Key Developments
10.3 Greiner Bio One International GmbH
10.3.1 Overview
10.3.2 Product/Business Segment Overview
10.3.3 Financial Updates
10.4 Improve Medical Technology Co. Ltd
10.4.1 Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financial Updates
10.5 Terumo Medical Corporation
10.5.1 Overview
10.5.2 Product/Business Segment Overview
10.5.3 Financial Updates
10.5.4 Key Developments
10.6 Bayer Cropscience Limited
10.6.1 Overview
10.6.2 Product/Business Segment Overview
10.6.3 Financial Updates
10.6.4 Key Developments
10.7 HTL-STREFA S.A.
10.7.1 Company Overview
10.7.2 Product/Business Segment Overview
10.7.3 Financial Updates
10.7.4 Key Development
10.8 Sarstedt AG & Co.
10.8.1 Overview
10.8.2 Product/Business Segment Overview
10.8.3 Financial Overview
11 Bibliography

TABLE 1 GLOBAL LANCET MARKET, BY TYPE US$ MILLION 21
TABLE 2 NORTH AMERICA LANCET MARKET, BY TYPE US$ MILLION 22
TABLE 3 US LANCET MARKET, BY TYPE US$ MILLION 23
TABLE 4 CANADA LANCET MARKET, BY TYPE US$ MILLION 24
TABLE 5 EUROPE LANCET MARKET, BY TYPE US$ MILLION 25
TABLE 6 GERMANY LANCET MARKET BY TYPE US$ MILLION 26
TABLE 7 FRANCE LANCET MARKET, BY TYPE US$ MILLION 26
TABLE 8 UK LANCET MARKET, BY TYPE US$ MILLION 27
TABLE 9 ITALY LANCET MARKET, BY TYPE US$ MILLION 28
TABLE 10 POLAND LANCET MARKET, BY TYPE US$ MILLION 28
TABLE 11 REST OF EUROPE LANCET MARKET, BY TYPE US$ MILLION 29
TABLE 12 ASIA PACIFIC LANCET MARKET, BY TYPE US$ MILLION 30
TABLE 13 JAPAN LANCET MARKET, BY TYPE US$ MILLION 31
TABLE 14 CHINA LANCET MARKET, BY TYPE US$ MILLION 31
TABLE 15 INDIA LANCET MARKET, BY TYPE US$ MILLION 32
TABLE 16 SOUTH KOREA LANCET MARKET, BY TYPE US$ MILLION 33
TABLE 17 REST OF ASIA-PACIFIC LANCET MARKET, BY TYPE US$ MILLION 33
TABLE 18 MIDDLE EAST & AFRICA LANCET MARKET, BY TYPE US$ MILLION 34
TABLE 19 UAE LANCET MARKET, BY TYPE US$ MILLION 35
TABLE 20 EGYPT LANCET MARKET, BY TYPE US$ MILLION 35
TABLE 21 SAUDI ARABIA LANCET MARKET, BY TYPE US$ MILLION 36
TABLE 22 REST OF MIDDLE EAST AND AFRICA LANCET MARKET, BY TYPE US$ MILLION 37
TABLE 23 GLOBAL LANCET MARKET, BY END USERS US$ MILLION 39
TABLE 24 US LANCET MARKET, BY END USERS US$ MILLION 41
TABLE 25 CANADA LANCET MARKET, BY END USERS US$ MILLION 41
TABLE 26 EUROPE LANCET MARKET, BY END USERS US$ MILLION 42
TABLE 27 GERMANY LANCET MARKET, BY END USERS US$ MILLION 43
TABLE 28 FRANCE LANCET MARKET, BY END USERS US$ MILLION 43
TABLE 29 UK LANCET MARKET, BY END USERS US$ MILLION 44
TABLE 30 ITALY LANCET MARKET, BY END USERS US$ MILLION 44
TABLE 31 POLAND LANCET MARKET, BY END USERS US$ MILLION 45
TABLE 32 REST OF EUROPE LANCET MARKET, BY END USERS US$ MILLION 45
TABLE 33 ASIA PACIFIC LANCET MARKET, BY END USERS US$ MILLION 46
TABLE 34 JAPAN LANCET MARKET, BY END USERS US$ MILLION 47
TABLE 35 CHINA LANCET MARKET, BY END USERS US$ MILLION 47
TABLE 36 INDIA LANCET MARKET, BY END USERS US$ MILLION 48
TABLE 37 SOUTH KOREA LANCET MARKET, BY END USERS US$ MILLION 48
TABLE 38 REST OF ASIA-PACIFIC LANCET MARKET, BY END USERS US$ MILLION 49
TABLE 39 MIDDLE EAST & AFRICA LANCET MARKET, BY END USERS US$ MILLION 49
TABLE 40 UAE LANCET MARKET, BY END USERS US$ MILLION 50
TABLE 41 EGYPT LANCET MARKET, BY END USERS US$ MILLION 51
TABLE 42 SAUDI ARABIA LANCET MARKET, BY END USERS US$ MILLION 51
TABLE 43 REST OF MIDDLE EAST AND AFRICA LANCET MARKET, BY END USERS US$ MILLION 52
TABLE 44 GLOBAL LANCET MARKET BY REGION US$ MILLION 54
TABLE 45 GLOBAL LANCET MARKET, BY REGION VOLUME (MILLIONS) 55
TABLE 46 NORTH AMERICA LANCET MARKET, BY COUNTRY US$ MILLION 55
TABLE 47 NORTH AMERICA LANCET MARKET, BY COUNTRY VOLUME (MILLION) 56
TABLE 48 EUROPE LANCET MARKET, BY COUNTRY US$ MILLION 57
TABLE 49 EUROPE LANCET MARKET, BY COUNTRY VOLUME (MILLION) 58
TABLE 50 ASIA PACIFIC LANCET MARKET, BY COUNTRY US$ MILLION 58
TABLE 51 ASIA PACIFIC LANCET MARKET, BY COUNTRY (VOLUME) 59
TABLE 52 MIDDLE EAST & AFRICA LANCET MARKET, BY COUNTRY US$ MILLION 60
TABLE 53 MIDDLE EAST & AFRICA LANCET MARKET, BY COUNTRY (VOLUME) 61
TABLE 54 LANCET PRICE INFORMATION 63
TABLE 55 HTL-STREFA S.A.: FINANCIAL REVENUE 77

FIGURE 1 FDA TIME LINE FOR LANCETS 10
FIGURE 2 RESEARCH PROCESS 14
FIGURE 3 PORTERS FIVE FORCES MODEL 18
FIGURE 4 SUPPLY CHAIN ANALYSIS 20
FIGURE 5 GLOBAL LANCET MARKET, BY TYPE 22
FIGURE 6 NORTH AMERICA LANCET MARKET, BY TYPE 23
FIGURE 7 EUROPE LANCET MARKET, BY TYPE 25
FIGURE 8 ASIA PACIFIC LANCET MARKET, BY TYPE 30
FIGURE 9 MIDDLE EAST & AFRICA LANCET MARKET, BY BLOOD LANCET 34
FIGURE 10 GLOBAL LANCET MARKET BY END USERS 38
FIGURE 11 GLOBAL LANCET MARKET, BY END USERS MARKET SHARE 2015 39
FIGURE 12 NORTH AMERICA LANCET MARKET, BY END USERS MARKET SHARE 2015 40
FIGURE 13 EUROPE LANCET MARKET, BY END USERS MARKET SHARE 2015 42
FIGURE 14 ASIA PACIFIC LANCET MARKET, BY END USERS MARKET SHARE 2015 46
FIGURE 15 MIDDLE EAST & AFRICA LANCET MARKET, BY END USERS MARKET SHARE 2015 50
FIGURE 16 GLOBAL LANCET MARKET, BY REGION MARKET SHARE 2015 54
FIGURE 17 NORTH AMERICA LANCET MARKET, BY COUNTRY MARKET SHARE 2015 56
FIGURE 18 EUROPE LANCET MARKET, BY COUNTRY MARKET SHARE 2015 57
FIGURE 19 ASIA PACIFIC LANCET MARKET, BY COUNTRY MARKET SHARE 2015 59
FIGURE 20 MIDDLE EAST & AFRICA LANCET MARKET, BY COUNTRY MARKET SHARE 2015 60
FIGURE 21 GLOBAL LANCET MARKET, MARKET SHARE ANALYSIS 2015 (%) 62
FIGURE 22 F. HOFFMANN-LA ROCHE AG: FINANCIAL REVENUE 65
FIGURE 23 F. HOFFMANN-LA ROCHE AG: SEGMENTAL REVENUE 65
FIGURE 24 BECTON, DICKINSON AND COMPANY: FINANCIAL REVENUE 67
FIGURE 25 BECTON, DICKINSON AND COMPANY: SEGMENTAL REVENUE 68
FIGURE 26 BECTON, DICKINSON AND COMPANY: GEOGRAPHICAL REVENUE 68
FIGURE 27 TERUMO: FINANCIAL REVENUE 72
FIGURE 28 TERUMO: SEGMENTAL REVENUE 73
FIGURE 29 TERUMO: GEOGRAPHICAL REVENUE 73
FIGURE 30 BAYER CROPSCIENCE: FINANCIAL REVENUE 74
FIGURE 31 BAYER CROPSCIENCE: SEGMENTAL REVENUE 75
FIGURE 32 BAYER CROPSCIENCE: GEOGRAPHICAL REVENUE 75

The post Global Lancet Market Analysis & Forecast 2016 To 2022 first appeared on CRI Report.

1 Report Prologue
2 Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
2.4 Market Structure
3 Research Methodology
3.1 Primary Research
3.2 Secondary Research
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Prevalence of the Chronic Diseases
4.2.2 Rise of Cholera
4.2.3 Growing acceptance of vitamin C intravenous for Colorectal Cancer
4.3 Restraints
4.3.1 Presence of Stringent Government Regulations
4.4 Opportunities
4.4.1 Rising continuous demand of IV solutions in U.S.
4.5 Challenge
4.5.1 Increasing Vitamin C Intravenous Therapy Prices
4.6 Mega Trends
4.7 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Porters five forces analysis
5.1.1 Introduction
5.1.2 Bargaining Power of Suppliers
5.1.3 Bargaining Power of Buyers
5.1.4 Threat of Substitutes
5.1.5 Rivalry
5.1.6 Threat of New Entrants
5.2 Value chain Analysis
5.2.1 Introduction
5.2.2 Inputs
5.2.3 Research & Development
5.2.4 Development Stage
5.2.5 Manufacturing process of IV solutions
5.2.6 Marketing and Distribution
5.3 Demand Supply Gap Analysis
5.4 Price factor analysis
5.5 Investment Feasibility Analysis
6 Global IV Solution Market, By Types
6.1 Introduction
6.2 Peripheral Parenteral Nutrition
6.3 Total Parenteral Nutrition
7 Global IV Solution Market, By Nutritional Content
7.1 Introduction
7.2 Amino Acid Solution
7.3 Carbohydrates
7.4 Vitamins & minerals
7.5 Parenteral lipid emulsion
7.6 Other Solutions
8 Global IV Solution Market, By End Users
8.1 Introduction
8.2 Hospital & Clinics
8.3 Ambulatory
8.4 Home Care
9 Global IV Solution Market, By Regions
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 Italy
9.3.4 UK
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Republic of Korea
9.4.5 Australia
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 UAE
9.5.2 Saudi Arabia
9.5.3 Egypt
9.5.4 Rest of Middle East & Africa
10 Company Share Analysis
11 Company Profiles
11.1 Baxter
11.1.1 Company Overview
11.1.2 Product/Business Segment Overview
11.1.3 Financial Overview
11.1.4 Key Development
11.1.5 SWOT Analysis
11.2 Fresenius Group
11.2.1 Company Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financial Overview
11.2.4 Key Development
11.2.5 SWOT Analysis
11.3 Braun Melsungen AG
11.3.1 Overview
11.3.2 Product/Business Segment Overview
11.3.3 Financial Updates
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 ICU Medical, Inc.
11.4.1 Company overview
11.4.2 Product Overview
11.4.3 Financials
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.5 Grifols S.A
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial Overview
11.5.4 Key Development
11.5.5 SWOT Analysis
11.6 Terumo Medical Corporation
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Amanta Healthcare
11.7.1 Company Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs
12.2 Key companies to watch
13 Appendix
13.1 Discussion Blue Print
13.2 References

TABLE 1 GLOBAL IV SOLUTIONS MARKET, BY TYPES USD MILLION (2014-2022)
TABLE 2 GLOBAL PERIPHERAL PARENTERAL NUTRITION MARKET BY REGION USD MILLION (2014-2022)
TABLE 3 GLOBAL TOTAL PARENTERAL NUTRITION MARKET BY REGION USD MILLION (2014-2022)
TABLE 4 GLOBAL IV SOLUTIONS MARKET, BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 5 GLOBAL AMINO ACID SOLUTION MARKET BY REGION USD MILLION (2014-2022)
TABLE 6 GLOBAL CARBOHYDRATES MARKET BY REGION USD MILLION (2014-2022)
TABLE 7 GLOBAL VITAMINS & MINERALS MARKET BY REGION USD MILLION (2014-2022)
TABLE 8 GLOBAL PARENTERAL LIPID EMULSION MARKET BY REGION USD MILLION (2014-2022)
TABLE 9 GLOBAL OTHER SOLUTIONS MARKET BY REGION USD MILLION (2014-2022)
TABLE 10 GLOBAL IV SOLUTIONS MARKET, BY END USERS USD MILLION (2014-2022)
TABLE 11 GLOBAL HOSPITAL & CLINICS MARKET BY REGION USD MILLION (2014-2022)
TABLE 12 GLOBAL AMBULATORY MARKET BY REGION USD MILLION (2014-2022)
TABLE 13 GLOBAL HOME CARE MARKET BY REGION USD MILLION (2014-2022)
TABLE 14 GLOBAL IV SOLUTIONS MARKET, BY REGION USD MILLION (2014-2022)
TABLE 15 NORTH AMERICA IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 16 NORTH AMERICA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 17 NORTH AMERICA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 18 NORTH AMERICA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 19 US IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 20 US IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 21 US IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 22 CANADA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 23 CANADA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 24 CANADA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 25 EUROPE IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 26 EUROPE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 27 EUROPE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 28 EUROPE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 29 GERMANY IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 30 GERMANY IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 31 GERMANY IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 32 FRANCE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 33 FRANCE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 34 FRANCE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 35 ITALY IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 36 ITALY IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 37 ITALY IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 38 UK IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 39 UK IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 40 UK IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 41 SPAIN IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 42 SPAIN IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 43 SPAIN IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 44 REST OF EUROPE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 45 REST OF EUROPE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 46 REST OF EUROPE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 47 ASIA PACIFIC IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 48 ASIA PACIFIC IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 49 ASIA PACIFIC IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 50 ASIA PACIFIC IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 51 JAPAN IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 52 JAPAN IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 53 JAPAN IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 54 CHINA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 55 CHINA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 56 CHINA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 57 INDIA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 58 INDIA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 59 INDIA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 60 REPUBLIC OF KOREA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 61 REPUBLIC OF KOREA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 62 REPUBLIC OF KOREA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 63 AUSTRALIA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 64 AUSTRALIA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 65 AUSTRALIA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 66 REST OF ASIA PACIFIC IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 67 REST OF ASIA PACIFIC IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 68 REST OF ASIA PACIFIC IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 69 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 70 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 71 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 72 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 73 UAE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 74 UAE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 75 UAE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 76 SAUDI ARABIA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 77 SAUDI ARABIA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 78 SAUDI ARABIA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 79 EGYPT IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 80 EGYPT IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 81 EGYPT IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 82 REST OF MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 83 REST OF MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 84 REST OF MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 85 BAXTER: KEY DEVELOPMENT
TABLE 86 FRESENIUS KABI AG: KEY DEVELOPMENT
TABLE 87 BRAUN MELSUNGEN AG: KEY DEVELOPMENT
TABLE 88 ICU MEDICAL INC.: KEY DEVELOPMENT
TABLE 89 GRIFOLS S.A.: KEY DEVELOPMENTS
TABLE 90 TERUMO MEDICAL CORPORATION: KEY DEVELOPMENTS 115

FIGURE 1 GLOBAL IV SOLUTIONS MARKET, BY TYPE, 2016 (%)
FIGURE 2 GLOBAL IV SOLUTIONS MARKET, BY NUTRITIONAL CONTENT, 2016 (%)
FIGURE 3 GLOBAL IV SOLUTIONS MARKET, BY END USER, 2016 (%)
FIGURE 4 GLOBAL IV SOLUTIONS MARKET, BY REGION, 2016 (%)
FIGURE 5 GLOBAL IV SOLUTIONS: MARKET STRUCTURE
FIGURE 6 RESEARCH PROCESS
FIGURE 7 GLOBAL IV SOLUTIONS MARKET: MARKET DYNAMICS
FIGURE 8 GROWTH DRIVERS: IMPACT ANALYSIS
FIGURE 9 GLOBAL IV SOLUTIONS MARKET, BY TYPES USD MILLION (2016 & 2022)
FIGURE 10 GLOBAL IV SOLUTIONS MARKET, BY NUTRITIONAL CONTENT USD MILLION (2016 & 2022)
FIGURE 11 GLOBAL IV SOLUTIONS MARKET, BY END USERS USD MILLION (2016 & 2022)
FIGURE 12 GLOBAL IV SOLUTIONS MARKET, BY REGION USD MILLION (2016 & 2022)
FIGURE 13 NORTH AMERICA IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 14 EUROPE IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 15 ASIA PACIFIC IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 16 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 17 COMPANY SHARE ANALYSIS
FIGURE 18 BAXTER: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 19 BAXTER: GEOGRAPHICAL MIX
FIGURE 20 BAXTER: OPERATING SEGMENTS
FIGURE 21 BAXTER: HOSPITAL PRODUCTS SEGMENT REVENUE
FIGURE 22 BAXTER: SWOT ANALYSIS
FIGURE 23 FRESENIUS GROUP: RECENT FINANCIAL: REVENUE (EURO MILLION) & R&D EXPENSES (%)
FIGURE 24 FRESENIUS GROUP: GEOGRAPHICAL MIX
FIGURE 25 FRESENIUS GROUP: OPERATING SEGMENTS
FIGURE 26 FRESENIUS GROUP: FRESENIUS KABI SEGMENT REVENUE
FIGURE 27 FRESENIUS KABI AG: SWOT ANALYSIS
FIGURE 28 BRAUN MELSUNGEN AG: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 29 BRAUN MELSUNGEN AG: BUSINESS REVENUE
FIGURE 30 BRAUN MELSUNGEN AG: B.BRAUN HOSPITAL CARE SEGMENT REVENUE
FIGURE 31 BRAUN MELSUNGEN AG: GEOGRAPHICAL REVENUE
FIGURE 32 BRAUN MELSUNGEN AG: SWOT ANALYSIS
FIGURE 33 ICU MEDICAL, INC: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 34 ICU MEDICAL, INC: GEOGRAPHICAL MIX
FIGURE 35 ICU MEDICAL, INC: SEGMENTAL MIX
FIGURE 36 ICU MEDICAL, INC.: INFUSION THERAPY SEGMENT REVENUE
FIGURE 37 ICU MEDICAL, INC: SWOT ANALYSIS
FIGURE 38 GRIFOLS S.A FINANCIAL OVERVIEW: RECENT FINANCIAL: REVENUE (US$ MILLION)
FIGURE 39 GRIFOLS S.A: RECENT FINANCIAL: OPERATING SEGMENTS
FIGURE 40 GRIFOLS S.A.: HOSPITAL SEGMENT REVENUE
FIGURE 41 GRIFOLS S.A FINANCIAL OVERVIEW: GEOGRAPHICAL REVENUE
FIGURE 42 SWOT ANALYSIS GRIFOLS S.A
FIGURE 43 TERUMO MEDICAL CORPORATION: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 44 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW SEGMENTAL OVERVIEW
FIGURE 45 TERUMO MEDICAL CORPORATION: GENERAL HOSPITAL COMPANY SEGMENT REVENUE
FIGURE 46 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW: GEOGRAPHICAL REVENUE
FIGURE 47 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW GEOGRAPHICAL OVERVIEW
FIGURE 48 SWOT ANALYSIS

The post Global IV solutions Market Analysis & Forecast 2016 To 2022 first appeared on CRI Report.

The market is majorly categorized on the basis of treatment & diagnostics which is further segmented into treatment and diagnostics. On the basis of treatment the market is segmented into positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, other devices, drugs, and surgery. On the basis of diagnostics the market is segmented into polysomnography and respiratory polygraphy and home oximetry and actigraph. On the basis of end users the market is segmented into hospitals and sleep laboratories, and home and geographic regions. Globally, North America holds the largest market share of global dental sleep medicine market, registering 56.4% % in 2016.
The scope of global dental sleep medicine market study includes the market value, market size and a detailed analysis of vendor products and strategies.
Key Players
The leading players of the global dental sleep medicine market are Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare, Drive DeVilbiss Healthcare, Curative Medical Inc., Apex Medical Corporation, BMC Medical Co. Ltd., Becton, Dickinson and Company and others.
Study Objectives of Dental sleep medicine Market Development and Demand Forecast to 2027 Market
 To provide insights about factors, influencing and affecting the market growth
 To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
 To provide historically and forecast revenue of the market segments based on type, and sub-segment for global dental sleep medicine market
 To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
 To provide economic factors that influence the global dental sleep medicine market

Target Audience
• Dental sleep medicine companies
• Hospitals & Clinics
• Raw Material Suppliers
• Key executive (CEO and COO) and strategy growth manager
Key Findings
• On the basis of treatment, the positive airway pressure (PAP) therapy dominates the segment with a share of 39.97% and growing with a CAGR of 9.24%.
• U.S. accounted for the largest market share of 85.00 % in 2016, which is expected to grow at a CAGR of 9.82 % during the forecast period from 2016 to 2023.

The reports also cover country level analysis:
• North America
• US
• Canada
• Europe
• Western Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Asia-Pacific
• China
• Japan
• India
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa

1 Report Prologue 9
2 Introduction 12
2.1 Scope of Study 12
2.2 Research Objective 12
2.3 Assumptions & Limitations 13
2.3.1 Assumptions 13
2.3.2 Limitations 13
2.4 Market Structure 13
3 Research Methodology 14
3.1 Research Process 14
3.2 Primary Research 15
3.3 Secondary Research 15
4 Market Factor Analysis 16
4.1 Porter’s Five Force Analysis 16
4.1.1 Bargaining Power of Buyer 17
4.1.2 Bargaining Power of Supplier 17
4.1.3 Threat from Substitute 18
4.1.4 Threat from a New Entrant 18
4.1.5 Intensity of Competitive Rivalry 18
4.2 Value Chain Analysis 19
4.2.1 Device Manufacturers 19
4.2.2 Software Developers 19
4.2.3 Healthcare Providers 19
4.2.4 Patients 19
5 Market Dynamics 20
5.1 Introduction 20
5.2 Drivers 21
5.2.1 Rise in risk factors is propelling the market growth 21
5.2.2 Rise in diseases and growing geriatrics population 21
5.2.3 Unmet needs 21
5.2.4 Growing awareness of sleep disorders 21
5.2.5 Technological advancements 22
5.3 Restraints 22
5.3.1 High cost and scanty presence of sleep labs 22
5.3.2 Late awareness and discomfort 22
5.3.3 Long-term dental changes 23
5.3.4 Lack of effectiveness and efficacy 23
5.4 Opportunities 23
5.4.1 Untapped market 23
5.4.2 Research and development 23
5.4.3 Personalized and customised solutions 24
5.4.4 Connected solutions and cloud based systems 24
5.5 Challenges 24
5.5.1 Poor standardization 24
5.5.2 Sub-standard products 25
6 Global Dental Sleep Medicine Market, By Treatment & Diagnostics 26
6.1 Introduction 26
6.2 Treatments 28
6.3 Diagnostics 29
7 Global Dental Sleep Medicine Market, By End Users 30
7.1 Introduction 30
7.2 Hospitals & Sleep Laboratories 31
7.3 Home 32
8 Global Dental Sleep Medicine Market, By Region 33
8.1 Introduction 33
8.2 North America 34
8.2.1 U.S. 36
8.2.2 Canada 38
8.3 Europe 39
8.3.1 Germany 41
8.3.2 France 43
8.3.3 U.K. 44
8.3.4 Italy 46
8.3.5 Spain 47
8.3.6 Rest of Europe 49
8.4 Asia Pacific 50
8.4.1 Japan 53
8.4.2 China 54
8.4.3 India 56
8.4.4 Australia 57
8.4.5 Republic of Korea 59
8.4.6 Rest of Asia Pacific 60
8.5 Middle East and Africa 62
8.5.1 Middle East 64
8.5.2 Africa 66
9 Company Profiling 68
9.1 Koninklijke Philips N.V. 68
9.1.1 Company Overview 68
9.1.2 Financial Overview 69
9.1.3 Key Developments 70
9.1.4 SWOT Analysis 71
9.2 ResMed 72
9.2.1 Company Overview 72
9.2.2 Financial Overview 72
9.2.3 Key Developments 73
9.2.4 SWOT Analysis 73
9.3 Fisher & Paykel Healthcare 74
9.3.1 Company Overview 74
9.3.2 Financial Overview 74
9.3.3 Key Developments 75
9.3.4 SWOT Analysis 75
9.4 Drive DeVilbiss Healthcare 76
9.4.1 Company Overview 76
9.4.2 Financial Overview 76
9.4.3 Key Developments 76
9.4.4 SWOT Analysis 77
9.5 Curative Medical Inc. 78
9.5.1 Company Overview 78
9.5.2 Financial Overview 78
9.5.3 Key Development 78
9.5.4 SWOT Analysis 79
9.6 Apex Medical Corporation 80
9.6.1 Company Overview 80
9.6.2 Financial Overview 80
9.6.3 Key Developments 80
9.7 BMC Medical Co. Ltd. 81
9.7.1 Company Overview 81
9.7.2 Financial Overview 81
9.8 Becton, Dickinson and Company 82
9.8.1 Company Overview 82
9.8.2 Financial Overview 82
9.8.3 Key Developments 82

TABLE 1 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 27
TABLE 2 GLOBAL DENTAL SLEEP MEDICINE TREATMENT MARKET, BY REGION, 2014-2023 (USD MILLION) 28
TABLE 3 GLOBAL DENTAL SLEEP MEDICINE DIAGNOSTICS MARKET, BY REGION, 2014-2023 (USD MILLION) 29
TABLE 4 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 30
TABLE 5 GLOBAL DENTAL SLEEP MEDICINE HOSPITALS AND SLEEP LABORATORIES MARKET, BY REGION,
2014-2023 (USD MILLION) 31
TABLE 6 GLOBAL DENTAL SLEEP MEDICINE HOME MARKET, BY REGION, 2014-2023 (USD MILLION) 32
TABLE 7 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY REGION, 2014-2023 (USD MILLION) 33
TABLE 8 NORTH AMERICA DENTAL SLEEP MEDICINE MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 34
TABLE 9 NORTH AMERICA DENTAL SLEEP MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 35
TABLE 10 NORTH AMERICA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 36
TABLE 11 U.S. DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 36
TABLE 12 U.S. DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 37
TABLE 13 CANADA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 38
TABLE 14 CANADA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 39
TABLE 15 EUROPE DENTAL SLEEP MEDICINE MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 39
TABLE 16 EUROPE DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 40
TABLE 17 EUROPE DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 41
TABLE 18 GERMANY DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 41
TABLE 19 GERMANY DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 42
TABLE 20 FRANCE DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 43
TABLE 21 FRANCE DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 44
TABLE 22 U.K. DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 44
TABLE 23 U.K DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 45
TABLE 24 ITALY DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 46
TABLE 25 ITALY DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 47
TABLE 26 SPAIN DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 47
TABLE 27 SPAIN DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 48
TABLE 28 REST OF EUROPE DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 49
TABLE 29 REST OF EUROPE DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 50
TABLE 30 ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 50
TABLE 31 ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 51
TABLE 32 ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 52
TABLE 33 JAPAN DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 53
TABLE 34 JAPAN DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 54
TABLE 35 CHINA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 54
TABLE 36 CHINA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 55
TABLE 37 INDIA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 56
TABLE 38 INDIA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 57
TABLE 39 AUSTRALIA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 57
TABLE 40 AUSTRALIA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 58
TABLE 41 REPUBLIC OF KOREA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 59
TABLE 42 REPUBLIC OF KOREA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 60
TABLE 43 REST OF ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 60
TABLE 44 REST OF ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 61
TABLE 45 MIDDLE EAST AND AFRICA DENTAL SLEEP MEDICINE MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 62
TABLE 46 MIDDLE EAST AND AFRICA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 63
TABLE 47 MIDDLE EAST AND AFRICA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 64
TABLE 48 MIDDLE EAST DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 64
TABLE 49 MIDDLE EAST DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 65
TABLE 50 AFRICA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 66
TABLE 51 AFRICA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 67
TABLE 52 PHILIPS RESPIRONICS: PRODUCT/BUSINESS SEGMENT OVERVIEW 68
TABLE 53 PHILIPS RESPIRONICS: KEY DEVELOPMENTS 70
TABLE 54 RESMED: PRODUCT/BUSINESS SEGMENT OVERVIEW 72
TABLE 55 RESMED: KEY DEVELOPMENTS 73
TABLE 56 FISHER & PAYKEL HEALTHCARE: PRODUCT/BUSINESS SEGMENT OVERVIEW 74
TABLE 57 FISHER & PAYKEL HEALTHCARE: KEY DEVELOPMENTS 75
TABLE 58 DEVILBISS HEALTHCARE: PRODUCT/BUSINESS SEGMENT OVERVIEW 76
TABLE 59 CURATIVE MEDICAL INC.: PRODUCT/BUSINESS SEGMENT OVERVIEW 78
TABLE 60 CURATIVE MEDICAL INC.: KEY DEVELOPMENT 78
TABLE 61 APEX MEDICAL CORPORATION: PRODUCT/BUSINESS SEGMENT OVERVIEW 80
TABLE 62 APEX MEDICAL CORPORATION: KEY DEVELOPMENTS 80
TABLE 63 BMC MEDICAL CO. LTD.: PRODUCT/BUSINESS SEGMENT OVERVIEW 81
TABLE 64 BECTON, DICKINSON AND COMPANY: PRODUCT/BUSINESS SEGMENT OVERVIEW 82
TABLE 65 BECTON, DICKINSON AND COMPANY: KEY DEVELOPMENTS 82

FIGURE 1 GLOBAL DENTAL SLEEP MEDICINE MARKET BY TREATMENT AND DIAGNOSTICS, 2016 (% MARKET SHARE) 10
FIGURE 2 GLOBAL DENTAL SLEEP MEDICINE MARKET BY TREATMENT, 2016 (% MARKET SHARE) 11
FIGURE 3 GLOBAL DENTAL SLEEP MEDICINE MARKET BY DIAGNOSTICS, 2016 (% MARKET SHARE) 11
FIGURE 4 MARKET STRUCTURE OF GLOBAL DENTAL SLEEP MEDICINE MARKET 13
FIGURE 5 RESEARCH PROCESS OF MRFR 14
FIGURE 6 PORTER FIVE FORCES ANALYSIS OF GLOBAL DENTAL SLEEP MEDICINE MARKET 17
FIGURE 7 DROC OF GLOBAL DENTAL SLEEP MEDICINE MARKET 20
FIGURE 8 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2016 & 2023
(USD MILLION) 28
FIGURE 9 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY END USERS 2016 & 2023 (USD MILLION) 31
FIGURE 10 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY REGION, 2016 & 2023 (USD MILLION) 34
FIGURE 11 NORTH AMERICA DENTAL SLEEP MEDICINE MARKET, BY COUNTRY MARKET SHARE 2015 (%) 35
FIGURE 12 EUROPE DENTAL SLEEP MEDICINE MARKET, BY COUNTRY MARKET SHARE 2016 (%) 40
FIGURE 13 ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY COUNTRY MARKET SHARE 2016 (%) 51
FIGURE 14 MIDDLE EAST AND AFRICA DENTAL SLEEP MEDICINE MARKET, BY COUNTRY MARKET SHARE 2016 (%) 62
FIGURE 15 KONINKLIJKE PHILIPS N.V.: RECENT FINANCIAL 69
FIGURE 16 KONINKLIJKE PHILIPS N.V.: GEOGRAPHICAL MIX 69
FIGURE 17 KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS 70
FIGURE 18 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS 71
FIGURE 19 RESMED: RECENT FINANCIAL 72
FIGURE 20 RESMED: SWOT ANALYSIS 73
FIGURE 21 FISHER & PAYKEL HEALTHCARE: RECENT FINANCIAL 74
FIGURE 22 FISHER & PAYKEL HEALTHCARE: SWOT ANALYSIS 75
FIGURE 23 DRIVE DEVILBISS HEALTHCARE: SWOT ANALYSIS 77
FIGURE 24 CURATIVE MEDICAL INC.: SWOT ANALYSIS 79
FIGURE 25 BECTON, DICKINSON AND COMPANY: RECENT FINANCIAL 82

The post Global Dental sleep medicine Market Analysis & Forecast To 2023 first appeared on CRI Report.

The purpose behind suturing is wound closure. Preferably, suturing should approximate the wound edges so that the tissues can restore closure with the last scar that is functional and aesthetic. The strategy and methods of suturing and also materials utilized are determinants as a part of the ultimate result.

The specialist should likewise have a full comprehension of wound healing, elasticity, and twisted conclusion to perform skin estimate. In a perfect world, the wound should be approximated with minimal pressure and the skin edges handled gently. It is the fine attention that the specialist provides for taking care of skin edges and the techniques of approximation that make the ideal aesthetic scar line.

In addition to legitimate technique, it is critical to choose the suitable type and size of suture material to ensure that wound edges are free of strain, permitting recuperating by primary intention. Suturing technique, the type and diameter of suture material, the type of surgical needle, and the design of the surgical knot are crucial variables in accomplishing ideal wound healing.

Wound closure variables are diverse when suturing over hard versus delicate tissue, or suturing over different types of materials put into the surgical site to advance periodontal recovery

Global Dental Insurance Market  Market Analysis and Forecast Report 2030

The global Dental Sutures market is expected to reach USD 779.1 million by 2027 at a CAGR of 6.1% during the forecasted period.

The global Dental Sutures market has been segmented on the basis of type which comprises Non-Absorbable Dental sutures, Absorbable Dental sutures and Others.

Of which Non-Absorbable Dental sutures segment holds 57.8% market share in global dental sutures market by type and expected to reach USD 463.7 million by 2027 from USD 221.5 million in 2016. Absorbable Dental sutures are expected to grow at a CAGR of 6.2% from 2016 to 2027.

On the basis of type of techniques it is segmented into Interrupted Sutures, continuous Sutures, Mattress Sutures. Of which Interrupted Sutures segment holds 45.9% market share of Dental Sutures by techniques and expected to reach US$ 373.0 million by 2027.

The global dental suture market is majorly categorized into; North America, Europe, Asia-Pacific and Middle East & Africa. The market is estimated at $383.2 million in 2016 and expected to reach at $779.1 million by 2027 at the rate of 6.1% from 2016-2027.

North America is the largest market for dental sutures. The large size of the market can be attributed to higher adoption of various dental suture devices coupled with presence of technologically advanced products. Earlier, periodontists were purchasing hospital format cyanoacrylate adhesive items that were intended for single-use wound closure circumstances in an emergency room setting.

The formulations and packaging were not customized to the necessities of the dental industry. Utilizing input from periodontists crosswise over North America, various products were developed in North America. Moreover, the high disposable income of the region also enables the professionals to opt for such devices.

Dentistry in the North America is in a condition of change with increasing population having periodontal diseases. The health care transmission framework is changing quickly with the execution of Affordable Care Act.

North America commands largest market share of 34.5% in 2015, while Asia-Pacific registers fastest growing CAGR of 6.6% between forecasted periods. Europe comprises of Germany, France, U.K, Italy, Spain and rest of Europe. Europe accounted for second-largest market share in global market.

Key Players

The leading market players in the global Dental Sutures market include: Hygitech SAS, DEMETECH CORPORATION, B. BRAUN MELSUNGEN AG, HANDONG SINORGMED CO., LTD, SURGICAL SPECIALTIES CORPORATION, ETHICON US, LLC, ASSUT EUROPE S.P.A, ERGON SUTRAMED S.P.A, OSTEOGENICS BIOMEDICAL

Study objectives

• To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Global dental sutures.

• To provide insights about factors influencing and affecting the market growth.

• To provide historical and forecast revenue of the market segments and sub-segments with respect to – Regional markets and their countries

• To provide historical and forecast revenue of the market segments based on type for Global dental sutures.

• To provide historical and forecast revenue of the market segments based on technique for Global dental sutures.

• To provide strategic profiling of key players in the market, comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market.

• To provide Economical factors that influences the Global dental sutures.To provide detailed analysis of the value chain and supply chain of the Global dental sutures

Target Audience

• Dental Sutures suppliers

• Dental Sutures manufacturers

• Dental research laboratories

• Potential Investors

• Medical Research Institutes

• Key Executive (CEO and COO) and Strategy Growth Manager

• Research Companies

Key Findings

• Non-Absorbable holds the largest market share for the Global dental suture market

• Most of the patients opt for non-absorbable, as the non-absorbable suture is been removed in couple of weeks and does not get dissolve in the tissue

• Interrupted Suture holds the largest share market with 57.6% of the Global dental suture market

• The routine interrupted suture is the one most usually utilized as a part of the oral cavity

• It is also the fasted growing technique with a CAGR of 6.5%

The report also covers regional analysis

• North America

o US

o Canada

• Europe

o Germany

o France

o U.K.

o Italy

o Spain

o Rest of Europe

• Asia Pacific

o Japan

o China

o India

o Republic of Korea

o Rest of Asia-Pacific

• Middle East & Africa

o Middle East

o Africa

TMJ Implants Market: Information by Component (Mandibular Components, Fossa Prostheses, Screws), by Material (Cobalt-Chromium-Molybdenum, Titanium Alloy, Ultra-High Molecular Weight Polyethylene, Aluminum, Silicon), by Indication (Arthritic Conditions, Ankylosis), by End User (Hospitals, Dental Clinics), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)-Forecast till 2027

The post Global Dental Sutures Market Analysis & Forecast 2016-2027 first appeared on CRI Report.